Joke Dyck - Info zur Person mit Bilder, News & Links



	Dirk Schrijvers Brande Marika Rasschaert Vermorken Docetaxel Danielle Specenier Weyngaert ALTINTAS Johan Bosmans

News

History of Changes for Study: NCT ClinicalTrials.gov

clinicaltrials.gov

Contact:Contact: Joke Dyck 32 (0) Contact:Principal Investigator: Manon Huizing, MD. Centre Hospitalier Universitaire de Liège › history

History of Changes for Study: NCT

clinicaltrials.gov

Contact:Contact: Joke Dyck 32 (0) Contact:Principal Investigator: Manon Huizing, MD. UZ Leuven, Campus Gasthuisberg, ...

Netzwerk-Profile

Facebook: Joke Dyck | Facebook

LinkedIn: Joke Dyck | LinkedIn

View Joke Dyck's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Joke Dyck discover inside ...

Bücher

SpringerCitations - Details Page

citations.springernature.com

Marika Rasschaert, Dirk Schrijvers, Jan Van den Brande, Joke Dyck, Johan Bosmans, Karlheinz Merkle and Jan B. Vermorken. Journal: Anti-Cancer Drugs, ...

Veröffentlichungen allgemein

A phase I study of bendamustine hydrochloride Wikidata

www.wikidata.org

Statements ; Marika Rasschaert · 1 ; Dirk Schrijvers · 2 ; Jan Van den Brande · 3 ; Joke Dyck · 4 ; Johan Bosmans · 5. › wiki

Overview of trials running in the Benelux

www.ariez.nl

von JF Baurain · — For more information please contact Joke Dyck, . • A randomized phase III trial of neoadjuvant chemotherapy followed by surgery ... von P Schöffski · — . •. Preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA trial).

Artikel & Meinungen

A phase I study of bendamustine hydrochloride Nature

www.nature.com

von M Rasschaert · · Zitiert von: 53 — We thank Joke Dyck and Veerle Nys for data management, Dr Möller (Bioproof, Munich) and Professor Preiss (University of Leipzig) for the ...

Sonstiges

(PDF) A Phase I Trial of Sorafenib Plus Gemcitabine and ...

www.academia.edu

Items — ... PhD,* Marika Rasschaert, MD,* Philippe Vroman, MD,w Jan Van den Brande, MD,* Joke Dyck, RN,* Dirk Schrijvers, MD, PhD,* Manon T. Huizing, ...

(PDF) Phase II feasibility study of concurrent radiotherapy and ...

www.academia.edu

Joke Dyck. J. Weyler. Danielle Van Den Weyngaert. Manon Huizing · Dirk Schrijvers. Jan Vermorken. DownloadDownload PDF. Full PDF PackageDownload Full PDF ... › Phase...

Docetaxel, Ifosfamide and Cisplatin Anticancer Research

ar.iiarjournals.org

POL M. SPECENIER, JAN VAN DEN BRANDE, DIRK SCHRIJVERS, MANON T. HUIZING, SEVILAY ALTINTAS, JOKE DYCK, DANIELLE VAN DEN WEYNGAERT, CARL VAN LAER and JAN B.

Docetaxel, Ifosfamide and Cisplatin (DIP) in Squamous Cell ...

ar.iiarjournals.org

... JAN VAN DEN BRANDE, DIRK SCHRIJVERS, MANON T. HUIZING, SEVILAY ALTINTAS, JOKE DYCK, DANIELLE VAN DEN WEYNGAERT, CARL VAN LAER and JAN B. VERMORKEN. › content

Docetaxel, ifosfamide and cisplatin (DIP) in PubMed

pubmed.ncbi.nlm.nih.gov

von PM Specenier · · Zitiert von: 7 — Pol M Specenier , Jan Van Den Brande, Dirk Schrijvers, Manon T Huizing, Sevilay Altintas, Joke Dyck, Danielle Van Den Weyngaert, Carl Van Laer, ... von M Rasschaert · · Zitiert von: 50 — Authors. Marika Rasschaert , Dirk Schrijvers, Jan Van den Brande, Joke Dyck, Johan Bosmans, Karlheinz Merkle, Jan B Vermorken ...

A phase I study of bendamustine hydrochloride administered once every...

pubmed.ncbi.nlm.nih.gov

The present phase I trial was planned to …s the maximum tolerated dose, the dose-limiting toxicity and the pharmacokinetics of bendamustine hydrochloride...

Docetaxel, ifosfamide and cisplatin in solid tumour treatment

pubmed.ncbi.nlm.nih.gov

von P Specenier · · Zitiert von: 1 — Authors. Pol Specenier , Marika Rasschaert, Jan Van den Brande, Joke Dyck, Dirk Schrijvers, Manon T Huizing, Jan B Vermorken ... › ...

A phase i study of DMS612, a novel bifunctional alkylating agent ...read.qxmd.com › read › a-phase-i-study-of-dms

read.qxmd.com

Pol Specenier, Marika Rasschaert, Jan Van den Brande, Joke Dyck, Dirk Schrijvers, Manon T Huizing, Jan B Vermorken Anti-cancer Drugs 2010, 21 (3):

Joe Dyck info - NameINF.me

joe-dyck.nameinf.me

... Joie Dyck, Jie dyck, Jo9e Dyck, J9e dyck, Jo0e Dyck, J0e dyck, Jope Dyck, Jpe dyck, Jole Dyck, Jle dyck, Joke Dyck, Jke dyck, Jo dyck, Joew Dyck, ...

Nuttige informatie | Thoracale Oncologie Groep Antwerpen

www.uantwerpen.be

Contact UZA. Head of Phase I Unit Prof. Dr. C Rolfo. Contact to refer a patient Joke Dyck › toga

Weekly Docetaxel in Patients With Recurrent and/or Metastatic ...

www.semanticscholar.org

... author={Pol Specenier and Marika Rasschaert and Philippe Vroman and Jan Van den Brande and Joke Dyck and Dirk Schrijvers and Manon T Huizing and Jan author={Marika Rasschaert and Dirk Schrijvers and Jan Van den Brande and Joke Dyck and J. M. L. Bosmans and Karlheinz Merkle and Jan Baptist Vermorken}, ... › ...